These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23244676)

  • 1. Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature.
    Storaas E; Holmaas G; Gravdal K; Børretzen A; Eikesdal HP
    Acta Oncol; 2013 Jun; 52(5):1034-8. PubMed ID: 23244676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fatal acute interstitial lung disease associated with docetaxel administration: about a case and review of the literature].
    Brahmi SA; Youssef S; Ziani FZ; Afqir S
    Pan Afr Med J; 2016; 24():119. PubMed ID: 27642457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.
    Pankowska-Supryn M; Załęska M; Roszkowska-Śliż B; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2015; 83(5):378-82. PubMed ID: 26378999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-induced Haemorrhagic Interstitial Pneumonitis - An Acute Life-threatening Adverse Effect.
    Chatterjee S; Pilaka VK; Mukhopadhyay S; Shrimali RK; Ahmed R
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):483-4. PubMed ID: 25911197
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute interstitial pneumopathy associated with docetaxel hypersensitivity.
    Karacan O; Eyüboglu FO; Akçay S; Ozyilkan O
    Onkologie; 2004 Dec; 27(6):563-5. PubMed ID: 15591716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature.
    Mileshkin L; Prince HM; Rischin D; Zimet A
    Bone Marrow Transplant; 2001 Mar; 27(5):559-63. PubMed ID: 11313694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer.
    Leimgruber K; Negro R; Baier S; Moser B; Resch G; Sansone S; Adami M; Zanon P; Graiff C; Egarter-Vigl E; Wiedermann CJ
    Tumori; 2006; 92(6):542-4. PubMed ID: 17260498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.
    Toulmonde M; Madranges N; Brouste V; Donamaria C; MacGrogan G; Durand M; Bonnefoi H; Mauriac L; Debled M
    Breast Cancer Res Treat; 2012 Jul; 134(1):325-32. PubMed ID: 22531859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lung injury associated with docetaxel and bevacizumab.
    Prat A; Martínez P; Serrano C; Montero MA; Andreu J; Cortés J
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):803-5. PubMed ID: 17889516
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe interstitial pneumonitis associated with docetaxel administration.
    Read WL; Mortimer JE; Picus J
    Cancer; 2002 Feb; 94(3):847-53. PubMed ID: 11857321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening interstitial lung disease associated with trastuzumab: case report.
    Pepels MJ; Boomars KA; van Kimmenade R; Hupperets PS
    Breast Cancer Res Treat; 2009 Feb; 113(3):609-12. PubMed ID: 18343993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment.
    Grande C; Villanueva MJ; Huidobro G; Casal J
    Clin Transl Oncol; 2007 Sep; 9(9):578-81. PubMed ID: 17921105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal pneumonitis after treatment with docetaxel and trastuzumab.
    Kuip E; Muller E
    Neth J Med; 2009 Jun; 67(6):237-9. PubMed ID: 19749395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flagellate erythema induced by docetaxel.
    Tallon B; Lamb S
    Clin Exp Dermatol; 2008 May; 33(3):276-7. PubMed ID: 18201264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer.
    Tamiya A; Naito T; Miura S; Morii S; Tsuya A; Nakamura Y; Kaira K; Murakami H; Takahashi T; Yamamoto N; Endo M
    Anticancer Res; 2012 Mar; 32(3):1103-6. PubMed ID: 22399640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe interstitial pneumonitis associated with the administration of taxanes.
    Nagata S; Ueda N; Yoshida Y; Matsuda H; Maehara Y
    J Infect Chemother; 2010 Oct; 16(5):340-4. PubMed ID: 20354889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of fulminant colitis after docetaxel therapy for breast carcinoma in a patient with underlying ulcerative colitis.
    Lalos AT; Bansal P; Rishikesh R
    Am J Gastroenterol; 2009 Oct; 104(10):2651-2. PubMed ID: 19806113
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal hypersensitivity pneumonitis associated with docetaxel.
    Gurram MK; Pulivarthi S; McGary CT
    Tumori; 2013; 99(3):e100-3. PubMed ID: 24158075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly docetaxel regimens and radiation pneumonitis.
    Mauri D; Tzachanis D; Tsekoura P; Xanthakis I; Tsali L; Roumbkou S; Fountzilas G
    J Support Oncol; 2008; 6(6):265-6. PubMed ID: 18724534
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature.
    D'Amato G; Rocha Lima C; Mahany JJ; Muro-Cacho C; Haura EB
    Lung Cancer; 2004 Jun; 44(3):381-90. PubMed ID: 15140552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.